Control of mammary stem cell function by steroid hormone signalling

Area of Science:

• Endocrinology
• Oncology
• Stem Cell Biology

Background:

• Ovarian hormones like oestrogen and progesterone significantly affect breast cancer risk and incidence.
• Endocrine therapies and ovarian ablation are established breast cancer treatments.
• The cellular mechanisms linking hormones, pregnancy, and breast cancer risk are not fully understood.

Purpose of the Study:

• To investigate the role of steroid hormone signaling in mouse mammary stem cells (MaSCs).
• To elucidate the cellular basis for pregnancy-associated breast cancer risk.
• To explore MaSC function as a target for breast cancer chemoprevention.

Main Methods:

• Studied MaSC number and function in mice under varying hormonal conditions (ovariectomy, hormone treatment, aromatase inhibition).
• Investigated the impact of pregnancy on MaSC populations.
• Assessed the role of RANK ligand in mediating pregnancy-induced MaSC changes.

Main Results:

• MaSCs responded to steroid hormone signaling despite lacking direct receptors.
• Ovariectomy reduced MaSC number and potential; hormone treatment increased them.
• Aromatase inhibitor treatment reduced the MaSC pool.
• Pregnancy caused a transient, significant increase in MaSC numbers, likely via RANK ligand.

Conclusions:

• MaSCs are key mediators of ovarian hormone effects on breast tissue.
• The pregnancy-induced increase in MaSCs provides a cellular explanation for elevated short-term breast cancer risk.
• Targeting MaSC function, potentially through hormone suppression, could be a viable breast cancer chemoprevention strategy.